Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 123534
Published online Oct 15, 2026. doi: 10.4251/wjgo.123534
Published online Oct 15, 2026. doi: 10.4251/wjgo.123534
Table 2 Reported synchronous or metachronous pancreatic and gallbladder epithelial tumors
| Ref. | Sex/age | Pancreatic lesion | Gallbladder lesion | Timing | Molecular/genetic evidence | Possible mechanism or key finding |
| Ueda et al[14] | Male/58 | Papillary adenocarcinoma | Papillary adenocarcinoma of the gallbladder and CBD | Synchronous | Not mentioned | Associated with anomalous arrangement of the pancreaticobiliary ductal system; gallbladder, CBD, and pancreatic duct tumors were not continuous |
| Sato et al[15] | Male/74 | Mucinous cystadenocarcinoma | Well-differentiated tubular adenocarcinoma of the gallbladder; poorly differentiated tubular adenocarcinoma of CBD | Synchronous | p53-positive nuclei were detected only in the pancreatic tumor | Triple synchronous tumors with different histopathology; findings suggested different oncogenic mechanisms rather than a single DNA-repair abnormality |
| Minami et al[16] | Female/50 | Moderately differentiated ductal adenocarcinoma | Moderately differentiated tubular adenocarcinoma | Metachronous; pancreatic cancer 10 years after cholecystectomy | Not mentioned | Associated with PBM without bile duct dilatation; emphasized long-term surveillance of the pancreas and biliary tract after biliary diversion |
| Lahmar et al[17] | Female/68 | Adenosquamous carcinoma | Moderately differentiated adenocarcinoma of the gallbladder invading CBD | Metachronous; pancreatic cancer 4 years after cholecystectomy | Not mentioned | Associated with PBM and cystic dilatation of the CBD; pancreatobiliary or biliopancreatic reflux was proposed as a carcinogenic mechanism |
| Chen et al[18] | Female/56 | Ductal adenocarcinoma | Well-differentiated adenocarcinoma | Metachronous; pancreatic cancer 3 years after cholecystectomy | Not mentioned | No recurrence after 33 months of follow-up after pancreaticoduodenectomy; mechanism not specified |
| Rungsakulkij and Boonsakan[19] | Female/46 | Well-differentiated ductal adenocarcinoma | Well-differentiated adenocarcinoma | Synchronous | Not mentioned | Associated with PBM and pancreaticobiliary reflux; authors emphasized the possibility of double primary cancer in PBM |
| Mori et al[20] | Female/72 | Moderately differentiated ductal adenocarcinoma | Well-differentiated tubular adenocarcinoma | Synchronous | Not mentioned | Associated with congenital biliary dilatation and PBM; reported as an extremely rare synchronous primary gallbladder-pancreatic cancer case in this setting |
| Ikeda et al[21] | Female/71 | IPMN with invasive carcinoma | Gallbladder cancer arising in polypoid lesions; histological not specified | Metachronous; pancreatic cancer 5 years after cholecystectomy | IHC: Pancreatic tumor MUC1+, MUC5AC+, MUC2- | Associated with non-dilated PBM; supports surveillance for pancreatic as well as biliary tract cancer in PBM |
| Kuhara et al[22] | Female/65 | First well-differentiated adenocarcinoma in pancreatic head; later moderately differentiated adenocarcinoma in remnant pancreas | Advanced papillary adenocarcinoma | Metachronous; pancreatic cancers 6.2 and 12.5 years after cholecystectomy | Not mentioned | Associated with PBM; bile pigment and marked inflammation in non-cancerous pancreatic ducts supported chronic inflammation and reflux-related carcinogenesis |
| Sato et al[23] | Male/72 | IPMN | Adenocarcinoma | Synchronous | IHC: MUC6-positive pyloric gland metaplasia in both the dilated pancreatic duct and gallbladder background mucosa | Associated with PBM; authors suggested a possible common phenotypic origin and recommended comprehensive pancreaticobiliary evaluation |
| Kato et al[24] | Female/77 | ITPN with invasive carcinoma | Papillary adenocarcinoma | Metachronous; pancreatic cancer 2 years after cholecystectomy | IHC: MUC1 focal weak+, MUC2-, MUC5AC- | Associated with PBM; supports careful long-term follow-up after diversion surgery because pancreatic or biliary cancers may still occur |
| Kogure et al[25] | Female/in her 80s | Adenosquamous carcinoma | Carcinoma; histological not specified | Synchronous | Not mentioned | Associated with PBM; co-occurrence of pancreatic adenosquamous carcinoma and gallbladder carcinoma was described as extremely rare |
| Miyazawa et al[26] | Male/63 | Adenocarcinoma | Gallbladder cancer; histological not specified | Metachronous; pancreatic cancer 5 years after cholecystectomy | Not mentioned | PBM was diagnosed after cholecystectomy; progressive pancreatic changes suggested biliopancreatic reflux-related pancreatic carcinogenesis |
| Present case | Female/30 | ITPN with multifocal invasive carcinoma | ICPN with high-grade dysplasia | Synchronous | No pathogenic variant identified by germline WES; somatic sequencing was not performed | No PBM was evident on available imaging; synchronous gallbladder ICPN and pancreatic ITPN suggest a possible field effect or shared epithelial susceptibility |
- Citation: He XX, Feng YL, Zhang ZW, Xu TM, Li JN. Synchronous intracholecystic papillary-tubular neoplasm and pancreatic intraductal tubulopapillary neoplasm: A case report. World J Gastrointest Oncol 2026; 18(10): 123534
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/123534.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123534